Anavex Life Sciences Corp. (AVXL)

3.125 -0.22 (-6.44%) USD  |  NASDAQ  |  May 07, 16:00
3.125 0.00 (0.00%) After-Hours: 20:00
More

Anavex Life Sciences Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for AVXL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Becton, Dickinson & Co. Upgrade
Nephros, Inc. Upgrade
Cabaletta Bio, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade